Myosana is a biotechnology company that develops and commercializes gene therapies for the treatment of muscle diseases.
$5M
Jan 24, 2023
-
AavantiBio is a Massachusetts-based biotechnology company that develops gene therapies for the treatment of cardiac and central nervous system dysfunctions.
$1.1M
Oct 15, 2020
-
Locana is a biotechnology company that develops and commercializes novel therapies for the treatment of chronical diseases and genetic disorders.
$550K
Jun 07, 2019
-
Akashi Therapeutics is a biopharmaceutical company develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases.
$1.5M
Jul 02, 2014
-
Valerian Therapeutics is a biotechnology firm that develops therapies for orphan genetic diseases.
$1.2M
May 29, 2013
-
Frequently Asked Questions about Muscular Dystrophy Association
What is Muscular Dystrophy Association investing in?
Muscular Dystrophy Association has invested in 7 companies including Myosana Therapeutics, AavantiBio and Locanabio
What company did Muscular Dystrophy Association invest in?
Muscular Dystrophy Association invested in a total 7 companies including Myosana Therapeutics, AavantiBio and Locanabio
What are the top 5 investments by Muscular Dystrophy Association?
The top companies in which Muscular Dystrophy Association invested are Myosana Therapeutics, AavantiBio, Locanabio, Akashi and Valerion Therapeutics
